ASTRAZENECA (ZEG HM) stock market data APIs
€118.6651
0.97(0.8%)
as of April 17, 2025
ASTRAZENECA Financial Data Overview
There is no Profile data available for ZEG.HM.
Prev. Close
118.6651
Open
119.6301
High
119.6301
Low
118.6651
52 wk Range
111.8-155.4349
Market Cap
148 612 M
Dividends (Yield)
0.0088
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ASTRAZENECA data using free add-ons & libraries
Get ASTRAZENECA Fundamental Data
ASTRAZENECA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ASTRAZENECA News
New
Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
(Bloomberg) -- Eli Lilly & Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative...
Six FTSE 100 stock ideas for the second quarter, according to Barclays
While uncertainty remains high as US president Donald Trump's fast-moving tariff agenda has prompted big moves in stock markets, Barclays (BARC.L) analysts have highlighted six UK stock ideas for the ...
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco
TSMC (2330.TW, TSM) Taipei-listed shares in Taiwan Semiconductor Manufacturing Company (2330.TW) surged nearly 10% on Thursday, after the chipmaker posted a 42% increase in revenue in the first quart...
AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY
AstraZeneca saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment and Imfinzi in...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
